LON:IBT International Biotechnology (IBT) Share Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free IBT Stock Alerts GBX 610 -2.00 (-0.33%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range 606▼ 62450-Day Range 612▼ 69452-Week Range 548▼ 704Volume60,001 shsAverage Volume58,382 shsMarket Capitalization£238.75 millionP/E Ratio580.95Dividend Yield4.59%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades Get International Biotechnology alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About International Biotechnology Stock (LON:IBT)International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.Read More IBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBT Stock News HeadlinesApril 18, 2024 | americanbankingnews.comInternational Biotechnology (LON:IBT) Stock Crosses Above 200-Day Moving Average of $627.46April 13, 2024 | nytimes.comBiotech Exec Gets 7 Years in Prison for False Claims About Rapid Covid-19 TestApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 10, 2024 | americanbankingnews.comInternational Biotechnology (LON:IBT) Stock Price Passes Above 200-Day Moving Average of $627.44April 3, 2024 | uk.finance.yahoo.comFidelity Asian Values Plc - Directorate ChangeApril 3, 2024 | bizjournals.comBioConsortia raises $15 million to expand Davis lab, field trialsApril 2, 2024 | msn.comBharat Biotech, Bilthoven Biologicals join forces to fortify global polio eradication effortsMarch 26, 2024 | gurufocus.comInternational Biotechnology Trust PLC Introductory Video TranscriptApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.March 25, 2024 | msn.comI'm a fund manager: Why biotech investor Ailsa Craig thinks rate cuts will spark a reboundMarch 9, 2024 | news.yahoo.comOur go-to guide for races in Livingston CountyFebruary 6, 2024 | investing.comInternational Biotechnology Trust plc (IBT)January 30, 2024 | marketwatch.comAvrobio to Merge With Tectonic Therapeutic in All-Stock DealJanuary 10, 2024 | benzinga.comComparing Biogen With Industry Competitors In Biotechnology IndustryJanuary 6, 2024 | reuters.comTrump meets Teamsters chief as union weighs presidential raceJanuary 4, 2024 | msn.comThis young biotech fund is worth a punt at a 25pc discountJanuary 3, 2024 | msn.comExclusive: Thermo Fisher halts DNA collection kit sales in TibetDecember 21, 2023 | businesswire.comImmunis Wins Two BASA Biotech Awards: “Best Small Business” and “Best Entrepreneur”December 17, 2023 | uk.finance.yahoo.comOzempic Maker’s Obesity-Fueled Gains Seen Slowing After Banner YearDecember 4, 2023 | tmcnet.comGlobal Bio-India 2023 attracts global interest for India's $300 billion biotech potential from companies, academia, and start-upsNovember 30, 2023 | msn.com4Moving Biotech shares innovative trial plans for GLP-1 osteoarthritis drugNovember 30, 2023 | markets.businessinsider.comCABIO unveils NeoHMOs™ series at FIE 2023, targeting growing global demand for infant formulaNovember 29, 2023 | msn.comBharat Biotech Collaborates With University Of Sydney For Vaccine Research CollaborationSeptember 21, 2023 | msn.comBharat Biotech nears phase III trials for tuberculosis vaccineSeptember 13, 2023 | au.finance.yahoo.comInternational Biotechnology Ord (IBT.L)July 20, 2023 | wsj.comTCM Biotech International Corp.July 10, 2023 | uk.movies.yahoo.comHardman & Co Research on International Biotechnology Trust (IBT): Industry M&A remains a key driverSee More Headlines Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 1/26 Dividend12/21/2023Dividend Payable1/26/2024Today4/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:IBT CUSIPN/A CIKN/A Webwww.ibtplc.com Phone44 20 7421 7070FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 1.05 Trailing P/E Ratio580.68 Forward P/E Ratio682.94 P/E GrowthN/ANet Income£43.12 million Net Margins84.61% Pretax MarginN/A Return on Equity15.33% Return on Assets9.20% Debt Debt-to-Equity Ratio8.19 Current Ratio0.27 Quick Ratio0.32 Sales & Book Value Annual Sales£50.96 million Price / Sales4.69 Cash FlowGBX 3.92 per share Price / Cash Flow155.74 Book ValueGBX 725 per share Price / Book0.84Miscellaneous Outstanding Shares39,140,000Free FloatN/AMarket Cap£238.75 million OptionableNot Optionable Beta0.18 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMs. Catherine Elizabeth Bingham M.B.A. (Age 58)Managing Partner Claire JacksonCompany SecretaryDr. Carl Harald JansonLead Investment ManagerKey CompetitorsCastelnau GroupLON:CGLJPMorgan US Smaller CompaniesLON:JUSCabrdn European Logistics IncomeLON:ASLIBaillie Gifford UK Growth TrustLON:BGUKMontanaro European SmallerLON:MTEView All CompetitorsInsidersCaroline GulliverBought 2,500 shares on 11/7/2023Total: £1.43 M ($573.00/share)Katherine Cornish-BowdenBought 1,500 shares on 8/3/2023Total: £949,500.00 ($633.00/share)View All Insider Transactions IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed in 2024? International Biotechnology's stock was trading at GBX 642 at the beginning of 2024. Since then, IBT stock has decreased by 5.0% and is now trading at GBX 610. View the best growth stocks for 2024 here. How often does International Biotechnology pay dividends? What is the dividend yield for International Biotechnology? International Biotechnology announced a dividend on Tuesday, December 12th. Shareholders of record on Thursday, December 21st will be given a dividend of GBX 13.90 per share on Friday, January 26th. This represents a yield of 2.21%. The ex-dividend date of this dividend is Thursday, December 21st. The official announcement can be seen at this link. Read our dividend analysis for IBT. Is International Biotechnology a good dividend stock? International Biotechnology (LON:IBT) pays an annual dividend of GBX 28 per share and currently has a dividend yield of 5.18%. IBT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 2,666.67%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for IBT. What other stocks do shareholders of International Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other International Biotechnology investors own include Oxford Pharmascience Group (OXP), Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR), Phoenix Group (PHNX), Riverstone Energy (RSE), Scirocco Energy Plc (SOLO.L) (SOLO) and Sirius Minerals (SXX). How do I buy shares of International Biotechnology? Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:IBT) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.